Stephen M. Simes (Vice-Chairman, President and Chief Executive Officer)
Mr. Simes has served as our Vice Chairman, President and Chief Executive Officer, and a director of our company since 1998.
From 1994 to 1997, Mr. Simes was President, Chief Executive Officer and a Director of Unimed Pharmaceuticals, Inc., (currently a wholly owned subsidiary of Abbott Laboratories) a company with a product focus on infectious diseases, AIDS, endocrinology and oncology. From 1989 to 1993, Mr. Simes was Chairman, President and Chief Executive Officer of Gynex Pharmaceuticals, Inc., a company which concentrated on the AIDS, endocrinology, urology and growth disorders markets. In 1993, Gynex was acquired by Savient Pharmaceuticals Inc. (formerly Bio-Technology General Corp.), and from 1993 to 1994, Mr. Simes served as Senior Vice President and director of Savient Pharmaceuticals Inc. Mr. Simes's career in the pharmaceutical industry started in 1974 with G.D. Searle & Co. (now a part of Pfizer Inc.). Mr. Simes currently serves as our designee on the board of directors of Ceregene, Inc., a privately held biotechnology company focused on the treatment of major neurodegenerative disorders using the delivery of nervous system growth factors.
Phillip B. Donenberg, CPA
(Senior Vice President, Finance, Chief Financial Officer and Secretary)
Mr. Donenberg currently serves as BioSante's Senior Vice President, Finance, Chief Financial Officer and Secretary. Prior to that he held the positions of Chief Financial Officer, Treasurer and Secretary from 1998 to 2010.
Before joining our company, Mr. Donenberg was Controller of Unimed Pharmaceuticals, Inc. (currently a wholly owned subsidiary of Abbott Laboratories) from 1995 to 1998. Prior to Unimed Pharmaceuticals, Inc., Mr. Donenberg held similar positions with other pharmaceutical companies, including Gynex Pharmaceuticals, Inc. (currently Savient Pharmaceuticals, Inc.), Applied NeuroSolutions, Inc. (formerly Molecular Geriatrics Corporation) and Xtramedics, Inc.
Joanne Zborowski (Vice President, Clinical Development)
Ms. Zborowski has served as our Vice President of Clinical Development since 2010. Prior to this Ms. Zborowski served as Director of Clinical Development since 2007 and has been with BioSante since 2002.
Before joining our company, Ms. Zborowski began her pharmaceutical industry career with Abbott Laboratories. From 1990 to 1998, she held positions in Medical Affairs and the Pharmaceutical Products Division where she worked on neuroscience, oncology and cardiovascular indications. Ms. Zborowski held similar consulting positions from 1999-2002.
Patricia Fuller (Vice President, Information Technology)
Ms. Fuller serves as our Vice President of Information Technology, having previously served as the Director of Information Technology since joining BioSante in 2011.
Ms. Fuller has extensive experience defining and implementing IT system solutions. From 1990 to 2011, Ms. Fuller was President of Technology Management Group, a consulting firm. Previously, Ms. Fuller was a consultant with McKinsey and Company, Inc. and prior to that, she was at IBM, managing several teams of engineers. Ms Fuller has a B.S. in Electrical Engineering from Northwestern University and an MBA from the University of Chicago.